🇺🇸 FDA
Patent

US 11912786

Inhibitor of apoptosis protein (IAP) antagonists

granted A61KA61K38/00A61P

Quick answer

US patent 11912786 (Inhibitor of apoptosis protein (IAP) antagonists) held by SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE expires Mon Feb 22 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE
Grant date
Tue Feb 27 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 22 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
17
CPC classes
A61K, A61K38/00, A61P, A61P1/00, A61P1/04